Intangible Assets (Details) - USD ($) |
Sep. 30, 2020 |
Sep. 30, 2019 |
|---|---|---|
| Intangible Assets | ||
| Clinical trial data | $ 250,000 | $ 250,000 |
| Accumulated Amortization and impairment | (250,000) | (104,167) |
| Intangible assets, net | $ 0 | $ 145,833 |
| X | ||||||||||
- Definition Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|